Company | Name | Exchange | Sector | Industry | 3 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Upgrade to Pro+ | Vienna | Healthcare | Biotechnology & Medical Research | 61.9% | €1.05B | 5.8x | 0.03 | €4.66 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Upgrade to Pro+ | Vienna | Industrials | Freight & Logistics Services | 38.3% | €844.53M | 12.6x | 3.18 | €9.40 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Upgrade to Pro+ | Vienna | Healthcare | Pharmaceuticals | 28% | €1.07B | 8.1x | 0.01 | €66.50 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Upgrade to Pro+ | Vienna | Healthcare | Pharmaceuticals | 19.1% | €1.88B | 10.9x | 0.34 | €24.21 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Upgrade to Pro+ | Vienna | Energy | Oil & Gas | 11.4% | €56.50B | 11x | -0.75 | €104.52 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Upgrade to Pro+ | Vienna | Healthcare | Biotechnology & Medical Research | 5.8% | €11.22B | 10.8x | 0.04 | €183.15 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Upgrade to Pro+ | Vienna | Utilities | Electrical Utilities & IPPs | 3.3% | €22.62B | 12.9x | -0.6 | €65.10 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.3% Downside | Upgrade to Pro+ | |
Upgrade to Pro+ | Vienna | Consumer Cyclicals | Media & Publishing | 1.4% | €1.80B | 17.2x | €3.83 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Upgrade to Pro+ | Vienna | Technology | Software & IT Services | -2% | €1.89B | 16.1x | 0.48 | €30 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |